Home > Footprints > Asia Pacific

Asia Pacific

Asia Pacific

Humanwell strives to be the leader in targeted market segments.

Humanwell’s business in the Asia Pacific region is mostly focused in China. Humanwell currently has 18 product groups, commanding over 60% market share in anesthetics, over 50% in Uygur medicines, and over 30% in fertility regulation medicines in China.

For decades, Humanwell sells finished products and APIs to many countries in Asia. Further, Humanwell is an emerging medical solutions provider in Vietnam, with anesthetic products on market since 2009.

Effective sales and marketing drives our rapid growth. Currently, Humanwell has 14 commercial task forces, over 2,500 dedicated sales professionals. The company’s distribution network has access to over 10,000, hospitals and 30,000 harmacies across Asia (mostly in Mainland China).